ArticleThe Journal of clinical investigation2001

Inhibition of cyclooxygenase-2 aggravates doxorubicin-mediated cardiac injury in vivo.

N P Dowd et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.